Andorra vs Iran, Islamic Republic of: Immunization, Hib3
Andorra
98.0%
in 2024
Iran, Islamic Republic of
98.0%
in 2024
Andorra rank
20th
Iran, Islamic Republic of rank
20th
Immunization, Hib3 over time
- Andorra
- Iran, Islamic Republic of
How they compare
Andorra currently reports 98.0% against 98.0% in Iran, Islamic Republic of, a difference of 0.0%.
Across all 10 years both countries report, Iran, Islamic Republic of has been ahead every year.
Andorra ranks 20th and Iran, Islamic Republic of ranks 20th of 191 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.2% | 98.8% | 0.6% | Iran, Islamic Republic of |
| 2020s | 97.6% | 98.6% | 1.0% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Andorra or Iran, Islamic Republic of?
- Andorra, at 98.0% against 98.0% in Iran, Islamic Republic of as of 2024.
- What is the difference in immunization, hib3 between Andorra and Iran, Islamic Republic of?
- 0.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Iran, Islamic Republic of?
- 10 years are reported by both, from 2015 to 2024.
- How do Andorra and Iran, Islamic Republic of rank globally for immunization, hib3?
- Andorra ranks 20th and Iran, Islamic Republic of ranks 20th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.